NCT04913285
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04913285
Title A Study to Evaluate KIN-2787 in Participants with BRAF And/or NRAS Mutation Positive Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Pierre Fabre Medicament
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ITA | FRA | ESP | AUS

Facility Status City State Zip Country Details
The Angeles Clinic Los Angeles California 90025-6602 United States Details
UCLA Los Angeles California 90095 United States Details
University of California San Diego, Moores Cancer Center San Diego California 92093 United States Details
University of California San Francisco San Francisco California 94143-2205 United States Details
Stanford Cancer Center Stanford California 94305 United States Details
Sarah Cannon Research Institute Denver Denver Colorado 80218-1238 United States Details
Mayo Clinic - Florida Jacksonville Florida 32224 United States Details
Sarah Cannon Research Institute - Florida Cancer Specialists Orlando Florida 32827 United States Details
Mayo Clinic - Rochester Rochester Minnesota 55905 United States Details
Atlantic Health Morristown New Jersey 07960 United States Details
Rutgers Cancer Institute of New Jersey New Brunswick New Jersey 08901 United States Details
NYU Langone New York New York 10016 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Cleveland Clinic Cleveland Ohio 44195 United States Details
Sarah Cannon Research Institute-Tennessee Oncology Nashville Tennessee 37203 United States Details
MD Anderson Houston Texas 77030 United States Details
Virginia Cancer Specialists Fairfax Virginia 22031 United States Details
Calvary Mater Hospital Newcastle Waratah New South Wales 2298 Australia Details
Melanoma Institute Australia Wollstonecraft New South Wales 2065 Australia Details
Tasman Health Care Southport Queensland 4215 Australia Details
Austin Health Heidelberg Victoria 3084 Australia Details
Linear Clinical Research Perth Western Australia 6009 Australia Details
Harbin Medical University Cancer Hospital Haerbin Heilongjiang 150081 China Details
Linyi Cancer Hospital Linyi Shandong 276001 China Details
Beijing University Cancer Hospital Beijing 100142 China Details
The Shanghai Pulmonary Hospital Shanghai 200433 China Details
Institut Bergonie Bordeaux France Details
Centre Francois Baclesse Caen France Details
CHU de Lille Lille France Details
Centre Leon Berard Lyon France Details
APHM-CHU La Timone Marseille France Details
CHU Nantes-Hotel Dieu Nantes France Details
CHU de Nice - Hôpital Archet 2 Nice France Details
APHP - Hôpital St Louis Paris France Details
Hospices Civiles de Lyon - Hôpital Lyon Sud Pierre-Bénite France Details
CHU de Poitiers Poitiers France Details
Oncopole Claudius Regaud Toulouse 31059 France Details
Gustave Roussy Villejuif 94805 France Details
Istituto Nazionale dei Tumori Fondazione G. Pascale Napoli 80131 Italy Details
Arance Barcelona Spain Spain Details
NEXT Quirónsalud Madrid Madrid Spain Spain Details
H. Regional de Málaga Málaga Spain Spain Details
H. Virgen Macarena Seville Spain Spain Details
Berrocal Valencia Spain Spain Details
Hospital Quiron Dexeus Barcelona Spain Details
Hospital Universitario Insular de Gran Canaria Las Palmas de Gran Canaria Spain Details
START Madrid Madrid 28050 Spain Details
Hospital General Gregorio Marañón Madrid 29009 Spain Details
INCLIVA (Hospital Clinico de Valencia) Valencia Spain Details
National Taiwan University Hospital Taipei Taiwan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field